Organon & Co. – Plans of Reorganization, Merger, Acquisition or Similar

NYSE: OGN
Share price (8/19/26): $13.73
Market cap (8/19/26): $3.606 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 96 pages Agreement and Plan of Merger Entered Into by and Among Organon & Co., Sun Pharmaceutical Holdings USA, Inc., Sun Pharma America, Inc. And, Solely for Purposes of the Covered Provisions, Sun Pharmaceutical Industries Limited, Sun Pharma Canada Inc., and Sun Pharma (Netherlands) B.V. Dated as of April 26, 2026

from 8-K 75 pages Separation and Distribution Agreement by and Between Merck & Co., Inc. and Organon & Co. Dated as of June 2, 2021

from 10-12B/A 73 pages Separation and Distribution Agreement by and Between Merck & Co., Inc. and Organon & Co. Dated as of June [ ], 2021